Correlation Between GlaxoSmithKline PLC and Vanguard Canadian

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and Vanguard Canadian at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and Vanguard Canadian into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and Vanguard Canadian Government, you can compare the effects of market volatilities on GlaxoSmithKline PLC and Vanguard Canadian and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of Vanguard Canadian. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and Vanguard Canadian.

Diversification Opportunities for GlaxoSmithKline PLC and Vanguard Canadian

0.56
  Correlation Coefficient

Very weak diversification

The 3 months correlation between GlaxoSmithKline and Vanguard is 0.56. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and Vanguard Canadian Government in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Vanguard Canadian and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with Vanguard Canadian. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Vanguard Canadian has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and Vanguard Canadian go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and Vanguard Canadian

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to under-perform the Vanguard Canadian. In addition to that, GlaxoSmithKline PLC is 4.16 times more volatile than Vanguard Canadian Government. It trades about -0.12 of its total potential returns per unit of risk. Vanguard Canadian Government is currently generating about 0.11 per unit of volatility. If you would invest  2,153  in Vanguard Canadian Government on August 29, 2024 and sell it today you would earn a total of  109.00  from holding Vanguard Canadian Government or generate 5.06% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy99.21%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  Vanguard Canadian Government

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
Vanguard Canadian 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Vanguard Canadian Government are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of very healthy basic indicators, Vanguard Canadian is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

GlaxoSmithKline PLC and Vanguard Canadian Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and Vanguard Canadian

The main advantage of trading using opposite GlaxoSmithKline PLC and Vanguard Canadian positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, Vanguard Canadian can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vanguard Canadian will offset losses from the drop in Vanguard Canadian's long position.
The idea behind GlaxoSmithKline PLC ADR and Vanguard Canadian Government pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sectors module to list of equity sectors categorizing publicly traded companies based on their primary business activities.

Other Complementary Tools

Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum